89 related articles for article (PubMed ID: 11139600)
1. Influence of adduct position and sequence length on the ligation of oligonucleotides containing benzo[c]phenanthrene diol epoxide-deoxyadenosine adducts into M13mp7L2.
Pontén I; Waters LS; Sayer JM; Pilcher AS; Dipple A; Jerina DM
Mutagenesis; 2001 Jan; 16(1):65-9. PubMed ID: 11139600
[TBL] [Abstract][Full Text] [Related]
2. Sequence context effects on mutational properties of cis-opened benzo[c]phenanthrene diol epoxide-deoxyadenosine adducts in site-specific mutation studies.
Pontén I; Sayer JM; Pilcher AS; Yagi H; Kumar S; Jerina DM; Dipple A
Biochemistry; 1999 Jan; 38(3):1144-52. PubMed ID: 9894012
[TBL] [Abstract][Full Text] [Related]
3. Mutational consequences of replication of M13mp7L2 constructs containing cis-opened benzo[a]pyrene 7,8-diol 9, 10-epoxide-deoxyadenosine adducts.
Page JE; Pilcher AS; Yagi H; Sayer JM; Jerina DM; Dipple A
Chem Res Toxicol; 1999 Mar; 12(3):258-63. PubMed ID: 10077488
[TBL] [Abstract][Full Text] [Related]
4. Targeted A --> T and G --> T mutations induced by site-specific deoxyadenosine and deoxyguanosine adducts, respectively, from the (+)-anti-diol epoxide of dibenz[a,j]anthracene in M13mp7L2.
Min Z; Gill RD; Cortez C; Harvey RG; Loechler EL; DiGiovanni J
Biochemistry; 1996 Apr; 35(13):4128-38. PubMed ID: 8672448
[TBL] [Abstract][Full Text] [Related]
5. Sequence context profoundly influences the mutagenic potency of trans-opened benzo[a]pyrene 7,8-diol 9,10-epoxide-purine nucleoside adducts in site-specific mutation studies.
Page JE; Zajc B; Oh-hara T; Lakshman MK; Sayer JM; Jerina DM; Dipple A
Biochemistry; 1998 Jun; 37(25):9127-37. PubMed ID: 9636059
[TBL] [Abstract][Full Text] [Related]
6. Factors determining mutagenic potential for individual cis and trans opened benzo[c]phenanthrene diol epoxide-deoxyadenosine adducts.
Pontén I; Sayer JM; Pilcher AS; Yagi H; Kumar S; Jerina DM; Dipple A
Biochemistry; 2000 Apr; 39(14):4136-44. PubMed ID: 10747805
[TBL] [Abstract][Full Text] [Related]
7. Effect of DNA base sequence on the configuration of deoxyadenosine adducts formed by the Fjord region diol epoxide, (+)-(1R,2S,3R,4S)-3,4-dihydroxy-1,2-epoxy-1,2,3,4- tetrahydrobenzo[c]phenanthrene.
Cheh AM; Yagi H; Jerina DM
Biochemistry; 1994 Nov; 33(43):12911-9. PubMed ID: 7947697
[TBL] [Abstract][Full Text] [Related]
8. Site-specific mutagenesis in Escherichia coli by N2-deoxyguanosine adducts derived from the highly carcinogenic fjord-region benzo[c]phenanthrene 3,4-diol 1,2-epoxides.
Ramos LA; Pontén I; Dipple A; Kumar S; Yagi H; Sayer JM; Kroth H; Kalena G; Jerina DM
Chem Res Toxicol; 2002 Dec; 15(12):1619-26. PubMed ID: 12482245
[TBL] [Abstract][Full Text] [Related]
9. Effect of benzo-ring hydroxyl groups on site-specific mutagenesis by tetrahydrobenzo[a]pyrene adducts at N(6) of deoxyadenosine.
Ramos LA; Sayer JM; Yagi H; Shah JH; Dipple A; Jerina DM
Chem Res Toxicol; 2001 Aug; 14(8):1082-9. PubMed ID: 11511182
[TBL] [Abstract][Full Text] [Related]
10. Sequence specific mutagenesis of the major (+)-anti-benzo[a]pyrene diol epoxide-DNA adduct at a mutational hot spot in vitro and in Escherichia coli cells.
Hanrahan CJ; Bacolod MD; Vyas RR; Liu T; Geacintov NE; Loechler EL; Basu AK
Chem Res Toxicol; 1997 Apr; 10(4):369-77. PubMed ID: 9114972
[TBL] [Abstract][Full Text] [Related]
11. Construction of Escherichia coli vectors containing deoxyadenosine and deoxyguanosine adducts from (+)-anti-dibenz[a,j]anthracene diol epoxide at a defined site.
Gill RD; Min Z; Cortez C; Harvey RG; Loechler EL; DiGiovanni J
Chem Res Toxicol; 1993; 6(5):681-9. PubMed ID: 8292747
[TBL] [Abstract][Full Text] [Related]
12. Differences between the mutational consequences of replication of cis- and trans-opened benzo[a]pyrene 7,8-diol 9,10-epoxide-deoxyguanosine adducts in M13mp7L2 constructs.
Pontén I; Kroth H; Sayer JM; Dipple A; Jerina DM
Chem Res Toxicol; 2001 Jun; 14(6):720-6. PubMed ID: 11409943
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of Werner syndrome helicase activity by benzo[c]phenanthrene diol epoxide dA adducts in DNA is both strand-and stereoisomer-dependent.
Driscoll HC; Matson SW; Sayer JM; Kroth H; Jerina DM; Brosh RM
J Biol Chem; 2003 Oct; 278(42):41126-35. PubMed ID: 12881525
[TBL] [Abstract][Full Text] [Related]
14. Marked differences in base selectivity between DNA and the free nucleotides upon adduct formation from Bay- and Fjord-region diol epoxides.
Vepachedu SR; Ya N; Yagi H; Sayer JM; Jerina DM
Chem Res Toxicol; 2000 Sep; 13(9):883-90. PubMed ID: 10995261
[TBL] [Abstract][Full Text] [Related]
15. Solution structure of a cis-opened (10R)-N6-deoxyadenosine adduct of (9S,10R)-9,10-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene in a DNA duplex.
Volk DE; Thiviyanathan V; Rice JS; Luxon BA; Shah JH; Yagi H; Sayer JM; Yeh HJ; Jerina DM; Gorenstein DG
Biochemistry; 2003 Feb; 42(6):1410-20. PubMed ID: 12578353
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and characterization of adducts derived from the syn-diastereomer of benzo[a]pyrene 7,8-dihydrodiol 9,10-epoxide and the 5'-d(CCTATAGATATCC) oligonucleotide.
Pontén I; Seidel A; Gräslund A; Jernström B
Chem Res Toxicol; 1996; 9(1):188-96. PubMed ID: 8924590
[TBL] [Abstract][Full Text] [Related]
17. Direct synthesis and characterization of site-specific adenosyl adducts derived from the binding of a 3,4-dihydroxy-1,2-epoxybenzo[c]phenanthrene stereoisomer to an 11-mer oligodeoxyribonucleotide.
Laryea A; Cosman M; Lin JM; Liu T; Agarwal R; Smirnov S; Amin S; Harvey RG; Dipple A; Geacintov NE
Chem Res Toxicol; 1995; 8(3):444-54. PubMed ID: 7578932
[TBL] [Abstract][Full Text] [Related]
18. Mutagenic potential of stereoisomeric bay region (+)- and (-)-cis-anti-benzo[a]pyrene diol epoxide-N2-2'-deoxyguanosine adducts in Escherichia coli and simian kidney cells.
Fernandes A; Liu T; Amin S; Geacintov NE; Grollman AP; Moriya M
Biochemistry; 1998 Jul; 37(28):10164-72. PubMed ID: 9665722
[TBL] [Abstract][Full Text] [Related]
19. Patterns of resistance to exonuclease digestion of oligonucleotides containing polycyclic aromatic hydrocarbon diol epoxide adducts at N6 of deoxyadenosine.
Ilankumaran P; Pannell LK; Gebreselassie P; Pilcher AS; Yagi H; Sayer JM; Jerina DM
Chem Res Toxicol; 2001 Sep; 14(9):1330-8. PubMed ID: 11559050
[TBL] [Abstract][Full Text] [Related]
20. Mutagenic and genotoxic effects of DNA adducts formed by the anticancer drug cis-diamminedichloroplatinum(II).
Yarema KJ; Lippard SJ; Essigmann JM
Nucleic Acids Res; 1995 Oct; 23(20):4066-72. PubMed ID: 7479066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
